ArticleInternational journal of molecular sciences2024

An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR-ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia.

Johanna Pohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.